Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox containing 1 (HMBOX1) is a transcription factor and telomere repeat-binding protein encoded by the HMBOX1 gene. It is not known as a receptor, enzyme, or established therapeutic target, but as a DNA-binding protein, it regulates gene expression, particularly in the context of telomere maintenance and chromatin organization[2][3][5]. HMBOX1 is widely expressed in normal tissues with uneven levels, showing particularly high expression in brain, adrenal gland, testis, and skin[2]. It plays diverse biological roles including transcriptional repression, modulation of cell differentiation, regulation of inflammation, apoptosis, and autophagy, and functions as a positive regulator of telomere length[2][3][5]. Experimental evidence suggests a context-dependent role in cancer biology, where HMBOX1 expression can promote or suppress tumor development depending on the cellular environment[2]. No drugs are known to directly target HMBOX1, and its main mechanisms of action involve DNA and telomeric chromatin binding, impacting transcription and telomere homeostasis[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox containing 1 (HMBOX1).